EZH2 enhances breast cancer initiation by directly binding to the NOTCH1 promoter and activates NOTCH1 signaling independent of its catalytic H3K27me3 activity (Gonzalez et al., 2014). This evidence concerns the gene EZH2 and breast carcinoma.